iRhythm Holdings (IRTC) Net Cash Flow (QoQ) (2016 - 2026)
iRhythm Holdings (IRTC) Net Cash Flow (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn |
| 10 | iRhythm Holdings | 3.72 Bn | 3.17 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.35% |
| Dec 31, 2025 | 63.31% |
| Sep 30, 2025 | 19.14% |
| Jun 30, 2025 | -49.35% |
| Mar 31, 2025 | 55.67% |
| Dec 31, 2024 | -222.16% |
| Sep 30, 2024 | -202.93% |
| Jun 30, 2024 | -93.88% |
| Mar 31, 2024 | 4,536.33% |
| Dec 31, 2023 | 21.67% |
| Sep 30, 2023 | -260.76% |
| Jun 30, 2023 | 133.88% |
| Mar 31, 2023 | -442.02% |
| Dec 31, 2022 | 125.34% |
| Sep 30, 2022 | -564.37% |
| Jun 30, 2022 | 119.73% |
| Mar 31, 2022 | 17.67% |
| Dec 31, 2021 | -239.69% |
| Sep 30, 2021 | 1,803.74% |
| Jun 30, 2021 | -96.93% |